October 8, 2025
Strategic Partnership with Leading Health Systems
Major hospital networks join forces with Aridol to expand patient access nationwide.
Read MoreFor Healthcare Professionals and Distributors only
Stay informed with the latest press releases, company announcements, and respiratory healthcare insights
The U.S. Food and Drug Administration has approved Aridol for use in children as young as 6 years old, marking a significant milestone in pediatric respiratory diagnostics. This expanded indication will enable earlier and more accurate asthma diagnosis in younger patients.
Major hospital networks join forces with Aridol to expand patient access nationwide.
Read MoreFive-year study demonstrates excellent tolerability across diverse populations.
Read MoreRegulatory milestone enables expanded availability across EU member states.
Read MoreOfficial company announcements and major milestones
Aridol now approved for children aged 6 and older, expanding access to advanced respiratory diagnostics for younger patients.
Strategic partnerships with major hospital networks will increase patient access to Aridol testing across the United States.
Five-year safety data demonstrates excellent tolerability with over 50,000 test administrations analyzed.
European regulatory approval paves the way for expanded availability across EU member states.
New certification program offers in-depth training on optimal test administration and result interpretation.
Second quarter results demonstrate strong market demand with 45% year-over-year revenue increase.
Important updates about our company, products, and services
We're excited to announce the launch of our redesigned website featuring enhanced resources for healthcare professionals, including interactive training modules, downloadable protocols, and a comprehensive knowledge base. Visit today to explore the new features.
Learn MoreJoin our expert team for a four-part webinar series starting November 5th. Topics include optimal patient preparation, advanced interpretation techniques, pediatric testing considerations, and quality assurance best practices. CME credits available.
Aridol has been recognized with the Innovation in Diagnostics Award at the American Thoracic Society International Conference. The award acknowledges our contribution to advancing respiratory diagnostic technology and improving patient care.
Read MoreAn updated product insert is now available reflecting the recent FDA approval for pediatric use. Healthcare professionals should review the updated prescribing information, including new dosing guidelines and safety information for pediatric patients.
Download Updated InsertAridol announces the appointment of Dr. Sarah Mitchell as Chief Medical Officer. Dr. Mitchell brings over 20 years of experience in pulmonary medicine and clinical research, and will lead our medical affairs and clinical development initiatives.
Read BiographyExpert perspectives on respiratory healthcare trends and best practices
Explore how innovative diagnostic approaches are transforming asthma management and improving patient outcomes. This comprehensive analysis examines current trends and future directions in respiratory diagnostics.
Evidence-based strategies for implementing bronchial challenge protocols that maximize diagnostic accuracy while ensuring patient safety and comfort. Learn from real-world clinical experiences.
A comprehensive guide to identifying and managing asthma in pediatric patients, including age-appropriate diagnostic approaches and treatment strategies for optimal long-term outcomes.
Examining worldwide challenges in respiratory healthcare delivery and innovative solutions to improve diagnostic access across diverse populations and healthcare systems.
Subscribe to our newsletter and never miss important updates, research insights, and educational content
Get breaking news and announcements before they're public
Access exclusive educational resources and insights
Early registration for webinars and training sessions